Overexpression of JARID1B is associated with poor prognosis and chemotherapy resistance in epithelial ovarian cancer

JARID1B Is a Luminal Lineage-Driving Oncogene in Breast Cancer

(2014) Shoji Yamamoto et al.   CANCER CELL

Overcoming Intrinsic Multidrug Resistance in Melanoma by Blocking the Mitochondrial Respiratory Chain of Slow-Cycling JARID1Bhigh Cells

(2013) Alexander Roesch et al.   CANCER CELL

Over-expression of LAPTM4B is associated with poor prognosis and chemotherapy resistance in stages III and IV epithelial ovarian cancer

(2011) Mingzhu Yin et al.   JOURNAL OF SURGICAL ONCOLOGY

A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth

(2010) Alexander Roesch et al.   CELL

LAPTM4B overexpression is a novel predictor of epithelial ovarian carcinoma metastasis

(2010) Mingzhu Yin et al.   INTERNATIONAL JOURNAL OF CANCER

Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data

(2010) MP Coleman et al.   LANCET